| | | | | |
HIO Western Asset High Income Opportunity Fund, Inc. | $3.6300 | +0.00% | $345.21M | $260.61K | |
SORN Soren Acquisition Corp. Class A Ordinary Shares | $9.9400 | +0.00% | $344.55M | $16.80K | |
SSSS SuRo Capital Corp. Common Stock | $13.2400 | +0.23% | $344.38M | $281.74K | |
BCML BayCom Corp Common Stock | $31.4300 | -0.38% | $344.18M | $131.14K | |
PRLD Prelude Therapeutics Incorporated | $4.3150 | -0.12% | $344.06M | $262.12K | |
HPF John Hancock Preferred Income Fund II | $15.8900 | +0.00% | $344.03M | $28.94K | |
GLSI Greenwich LifeSciences, Inc. | $23.6900 | +1.33% | $343.17M | $785.00 | |
FNLC First Bancorp, Inc. (ME) | $30.3800 | +0.00% | $342.55M | $53.00 | |
RM REGIONAL MANAGEMENT CORP | $37.2000 | +0.00% | $342.54M | $30.87K | |
HCMA HCM III Acquisition Corp. Class A Ordinary Share | $10.2650 | -0.15% | $342.39M | $5.50K | |
| $4.0700 | +0.00% | $342.23M | $689.56K | |
CHMG Chemung Financial Corp | $70.8500 | -0.17% | $342.06M | $87.90K | |
DSAC Daedalus Special Acquisition Corp. Class A Ordinary Shares | $10.0500 | +0.00% | $341.88M | $3.30K | |
CURR Currenc Group Inc. Ordinary Shares | $3.0400 | +0.33% | $340.21M | $31.00 | |
UPB Upstream Bio, Inc. Common Stock | $6.2350 | -0.24% | $340.12M | $24.00 | |
